Yahoo! Finance Search - Finance Home - Yahoo! - Help

Sunday, November 23 2014 11:17am ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Other News
Latest News
Friday, Nov 21, 2014
·ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Fri 6:27 pm ET
·Podcast: Do Allergan, Actavis, and Ackman Hint at a Market Top?
at The Wall Street Journal Online - Fri 3:49 pm ET
·Allergan deal sits well on Actavis chief's 'Monopoly board'
at - Fri Nov 21
·Orexigen Announces Allowance of New U.S. Patent for Contrave® (naltrexone HCl / bupropion HCl extended release)
PR Newswire - Fri Nov 21
Thursday, Nov 20, 2014
·ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium
PR Newswire - Thu Nov 20
·Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference
PR Newswire - Thu Nov 20
·[$$] Valeant Sets $2 Billion Buyback Plan
at The Wall Street Journal Online - Thu Nov 20
·U.S. court denies Ranbaxy's bid to block launch of rival generics
Reuters - Thu Nov 20
·Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets
Business Wire - Thu Nov 20
·Endo Announces Launch of Generic Version of Valcyte®
CNW Group - Thu Nov 20
·Endo Announces Launch of Generic Version of Valcyte®
PR Newswire - Thu Nov 20
·U.S. court overturns bid by India's Ranbaxy to block launch of rival generic drugs
Reuters - Thu Nov 20
Wednesday, Nov 19, 2014
·Ranbaxy Loses Bid to Block Rivals in Generic Drugs Fight
at Bloomberg - Wed Nov 19
·AGN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc
Business Wire - Wed Nov 19
·Is Orexigen Really Worth Over 50% More?
- Wed Nov 19
·That's Funny, you Look Just Like Allergan CEO David Pyott
at The Wall Street Journal Online - Wed Nov 19
·Allergan's Price Tag Gets Even Richer
at The Wall Street Journal Online - Wed Nov 19
·Synergy Pharmaceuticals Announces Positive Results of SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation
Business Wire - Wed Nov 19
·Can the Uptrend Continue for Allergan (AGN)? - Wed Nov 19
·Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals
PR Newswire - Wed Nov 19
More Latest News...
Sponsor Results
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
Industry News & Insights
Learn more about Industry News from the CSG Newsroom.
Lumosity Brain Games
Challenge memory and attention with scientific brain games.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?